Morpholino

MO2-cisha

ID
ZDB-MRPHLNO-151021-8
Name
MO2-cisha
Previous Names
  • cish.a ATG (1)
  • MO2-cish
Target
Sequence
5' - GCCTTCAACGCACAATATCATAAT - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-cisha
Expressed Gene Anatomy Figures
cisha Fig. 5 from Lewis et al., 2014
csf3r Fig. 4 from Lewis et al., 2014
epor Fig. 3 from Lewis et al., 2014
foxn1 Fig. 4 from Lewis et al., 2014
gata1a Fig. 3 from Lewis et al., 2014
ikzf1 Fig. 3,  Fig. 4 from Lewis et al., 2014
lck Fig. 4 from Lewis et al., 2014
lyz Fig. 4 from Lewis et al., 2014
mmp9 Fig. 4 from Lewis et al., 2014
mpx Fig. 4 from Lewis et al., 2014
rag1 Fig. 4 from Lewis et al., 2014
runx1 Fig. 3,  Fig. 4 from Lewis et al., 2014
socs1a Fig. 5 from Lewis et al., 2014
socs2 Fig. 5 from Lewis et al., 2014
spi1b Fig. 3,  Fig. 4 from Lewis et al., 2014
tal1 Fig. 3 from Lewis et al., 2014
trac Fig. 4 from Lewis et al., 2014
Phenotype
Phenotype resulting from MO2-cisha
Phenotype Fish Figures
blood island distended, abnormal WT + MO2-cisha Fig. 2 from Lewis et al., 2014
cell surface receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
common myeloid progenitor spi1b expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
erythroblast increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
erythroid lineage cell epor expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
erythroid lineage cell gata1a expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
granulocyte mmp9 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
hematopoietic multipotent progenitor cell ikzf1 expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
monocyte increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
myeloid cell increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
myeloid cell lyz expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
myeloid cell spi1b expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
myeloid cell csf3r expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
nucleate erythrocyte increased amount, abnormal WT + MO2-cisha Fig. 2 from Lewis et al., 2014
positive regulation of receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
T cell increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte rag1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte ikzf1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte lck expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte trac expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism trac expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism runx1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism lck expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism foxn1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism mmp9 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism cisha expression increased amount, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
whole organism lyz expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism ikzf1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism epor expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
whole organism rag1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism socs1a expression increased amount, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
whole organism socs2 expression increased amount, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
Phenotype of all Fish created by or utilizing MO2-cisha
Phenotype Fish Conditions Figures
myeloid cell csf3r expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
positive regulation of receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
whole organism rag1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
common myeloid progenitor spi1b expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
thymus lymphocyte ikzf1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
erythroid lineage cell gata1a expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
cell surface receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
thymus lymphocyte lck expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
blood island distended, abnormal WT + MO2-cisha standard conditions Fig. 2 from Lewis et al., 2014
whole organism epor expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
whole organism socs1a expression increased amount, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
whole organism runx1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
thymus lymphocyte trac expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism cisha expression increased amount, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
thymus lymphocyte increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
monocyte increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
whole organism lyz expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism ikzf1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
erythroblast increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
granulocyte mmp9 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism foxn1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism socs2 expression increased amount, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
erythroid lineage cell epor expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
myeloid cell spi1b expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
hematopoietic multipotent progenitor cell ikzf1 expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
whole organism trac expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
myeloid cell increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism lck expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
T cell increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
nucleate erythrocyte increased amount, abnormal WT + MO2-cisha standard conditions Fig. 2 from Lewis et al., 2014
thymus lymphocyte rag1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism mmp9 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
myeloid cell lyz expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.